Medications for Philadelphia Chromosome Positive Chronic Myelogenous Leukemia

3 results

  • iclusig - ponatinib hydrochloride tablet, film coated

    (Ponatinib Hydrochloride)
    Takeda Pharmaceuticals America, Inc.
    Iclusig treats adults with Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) — newly diagnosed with chemotherapy or T315I-positive — and chronic myeloid leukemia (CML), including chronic, accelerated, and blast phases, for patients resistant or intolerant to prior kinase inhibitors or with T315I mutation.
    Medication Details
    Drug Interactions

  • scemblix - asciminib tablet, film coated

    (Asciminib)
    Novartis Pharmaceuticals Corporation
    Scemblix treats Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML) in chronic phase in adults, including newly diagnosed patients, previously treated patients, and those with the T315I mutation.
    Medication Details
    Drug Interactions

  • sprycel - dasatinib tablet

    (Dasatinib)
    E.R. Squibb & Sons, L.L.C.
    Sprycel treats Ph+ chronic myeloid leukemia (CML) in adults—newly diagnosed or resistant/intolerant to prior therapy—and Ph+ acute lymphoblastic leukemia (Ph+ ALL). Also indicated for pediatric patients aged 1 year and older with Ph+ CML in chronic phase, and newly diagnosed Ph+ ALL with chemotherapy.
    Medication Details
    Drug Interactions